The Office of the U.S. Trade Representative on Thursday launched an investigation against Germany under Section 301 of the Trade Act of 1974 to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory and burdens or restricts U.S. commerce.
China on Thursday said that the investigations conducted by the European Union (EU) into Chinese firms constituted "unfair trade and investment barriers," News.az reports citing Deutsche Welle.
19 Jun 2026-07:22
09 Jan 2025-11:51
